# Dermatrix Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/dermatrix-co

- Industry: Software
- Headquarters: Daegu, South Korea
- Website: www.dermatrix.io/
- Latest round: Seed (Feb 3, 2026)
- Investors on record: 1

## About

Dermatrix Co., Ltd., headquartered in Daegu, South Korea, specializes in advanced clinical image management solutions tailored for dermatology practices, facilitating enhanced data organization and accessibility.Founded in 2025 in Daegu, South Korea, Dermatrix Co., Ltd. focuses on providing innovative clinical image management systems. The company has successfully completed one funding deal, most recently on February 3, 2026, securing investment from Bluepoint Partners to enhance its operational capabilities. Details about the founder's previous ventures are not available.Dermatrix specializes in a Clinical Image Management System (CLIMS) specifically designed for dermatology practices, providing secure storage, rapid search capabilities, and efficient data utilization. The core product, DermaView, addresses the challenges dermatologists face in managing clinical images by automating the organization and retrieval processes, significantly reducing manual workloads. Released after identifying a gap in the tools available for dermatology residents, the system streamlines the management of extensive image datasets, enabling users to sort images by date and input related information seamlessly. Dermatrix primarily serves hospitals and patients within the dermatology sector, enhancing patient care through improved data access and management. The company operates in various geographical markets, although specific regions are not detailed.Dermatrix's revenue model is structured around the provision of its flagship product, the Clinical Image Management System (CLIMS), through subscription or licensing agreements with healthcare institutions. Transactions typically occur on a B2B basis, wherein dermatology clinics and hospitals subscribe to the software for their image management needs, allowing for scalable use based on patient volume and clinic size. Pricing plans may vary depending on the client’s requirements and the scale of implementation. Clients benefit from a system that automates previously time-consuming tasks, ultimately improving operational efficiency and patient care. The revenue generated from these transactions reflects the increasing demand for innovative solutions in clinical data management.In February 2026, Dermatrix Co., Ltd. raised an undisclosed amount of Seed funding from new investor Bluepoint Partners. The company will use the funding to bolster its research and development capabilities and expand the scope of its services. Future growth plans include the design and launch of new products aimed at enhancing the functionality of their clinical image management solutions, as well as targeted expansion into additional geographic markets to broaden their service reach.

## Funding rounds

- Seed, Feb 3, 2026 — Bluepoint Partners

## Investors

- Bluepoint Partners (https://capitalatlas.ai/funds/bluepoint-partners) — Seed